Mercè Amat
Chief Tech/Sci/R&D Officer at Archivel Farma SL
Profile
Mercè Amat is currently the Head of Research & Development at Archivel Farma SL since 2008.
She has an undergraduate and doctorate degree from the University of Barcelona.
Mercè Amat active positions
Companies | Position | Start |
---|---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Chief Tech/Sci/R&D Officer | 2007-12-31 |
Training of Mercè Amat
University of Barcelona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Commercial Services |
- Stock Market
- Insiders
- Mercè Amat